Used primarily as an intermediate in the synthesis of biologically active compounds, particularly carbonic anhydrase inhibitors in the development of pharmaceuticals for treating conditions such as glaucoma, elevated intracranial pressure, and certain respiratory diseases. Its structure supports derivatization for use in drug discovery, especially in creating agents with potential antimicrobial, anti-inflammatory, or central nervous system activity. The sulfonamide group enhances solubility and binding characteristics, making it valuable in medicinal chemistry. Also employed in agrochemical research for designing novel pesticides and herbicides due to its stability and reactivity profile.